Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations.
about
The application of mass-spectrometry-based protein biomarker discovery to theragnosticsSeparation of peptides with polyionic nanosponges for MALDI-MS analysis.Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer.New pre-analytical approach for the deep proteome analysis of sera from pancreatitis and pancreas cancer patients.Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS.Proteomic analysis of multiple myeloma: current status and future perspectives.Novel Sample Preparation for Mass Spectral Analysis of Complex Biological Samples.Comparative proteomic profiles of Aspergillus fumigatus and Aspergillus lentulus strains by surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS)Biomarker discovery in neurodegenerative diseases: a proteomic approach.Biomarker discovery in serum from patients with carotid atherosclerosisDiscovery and verification of amyotrophic lateral sclerosis biomarkers by proteomicsPotential role of proteomics in the diagnosis of lymphoma: a meta-analysis.The value of surface enhanced laser desorption/ionization-time of flight mass spectrometry at the diagnosis of non-small cell lung cancer: a systematic review.Comparative mitochondrial proteomics: perspective in human diseases.Prognostic prediction by liver tissue proteomic profiling in patients with colorectal liver metastases.LC-MS for protein characterization: current capabilities and future trends.Urine in clinical proteomics.Better cancer biomarker discovery through better study design.Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins.Proteomic profiling of mitochondria: what does it tell us about the ageing brain?Tsetse flies, trypanosomes, humans and animals: what is proteomics revealing about their crosstalks?Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.Biomarkers for early detection of ovarian cancer.Proteomics of human seminal plasma: identification of biomarker candidates for fertility and infertility and the evolution of technology.Delineating the synovial fluid proteome: recent advancements and ongoing challenges in biomarker research.
P2860
Q28748224-C6F66538-DA6D-4938-8320-9EE86A8893A5Q33397579-83660FB3-2B7A-4E6B-9431-97FA174D6A0BQ33520447-7FB159B8-C124-43DB-8229-CB0F77536749Q33597715-C3984753-B516-4FF9-8128-136CFA297D73Q33683860-B2132D49-9581-47BC-A4FE-B332F11C86A3Q33802213-2CD1415A-A5E3-4CB1-9BE1-246DA91AB45AQ33807327-3B812777-5A29-4B49-A145-D99E3130B8DBQ33952033-5C7B0DA8-E8ED-42AF-9151-2D963DC227CFQ33974176-9B937B79-75DC-468E-B61F-EECB083FFDECQ34125681-692A50B1-152E-4C8D-907C-EBDFB76DF07FQ34261476-DCA54BAB-64A2-43B4-B39F-2F5B4A31670DQ34285662-E3A1DC7E-7BE9-4DD2-862A-83B3C8F251E8Q34502670-299F820B-C168-42A8-8F31-8664D66EC7D0Q34829225-21974243-E602-4143-BD0A-A64859CBDB0BQ35914386-12751903-2C44-4DA2-9E26-73F9F580A1DAQ36250018-2B6D6D9E-5FB5-4A04-BADA-5198B48FA7D2Q37183085-8BEA3EAF-D7A6-4AEA-990A-521C380AB799Q37230698-1C5093DE-533A-48B9-A727-FAEA024740DEQ37310041-3DBC26BB-8F60-458F-9EE5-5A8A3DD68F84Q37337498-6277A308-3093-4B65-BB6E-A56B2A043F06Q37610171-A7B848ED-D258-4B23-8A25-51DC1BACE02AQ37685121-3B3C4C94-E792-4DFE-8F01-2CA441897CF8Q37871569-0041F3CC-3E47-4BFC-9C2B-40CDFF27C32FQ38087982-2E0402D8-E337-4B33-BB75-B3857492BA59Q38096334-5DE2FEFB-6B93-4E5A-A542-97A8AC53A10BQ38113846-F684C3E5-1283-4E29-AE93-815FBD9B7522
P2860
Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Use of SELDI-TOF mass spectrom ...... rs: potential and limitations.
@ast
Use of SELDI-TOF mass spectrom ...... rs: potential and limitations.
@en
Use of SELDI-TOF mass spectrom ...... rs: potential and limitations.
@nl
type
label
Use of SELDI-TOF mass spectrom ...... rs: potential and limitations.
@ast
Use of SELDI-TOF mass spectrom ...... rs: potential and limitations.
@en
Use of SELDI-TOF mass spectrom ...... rs: potential and limitations.
@nl
prefLabel
Use of SELDI-TOF mass spectrom ...... rs: potential and limitations.
@ast
Use of SELDI-TOF mass spectrom ...... rs: potential and limitations.
@en
Use of SELDI-TOF mass spectrom ...... rs: potential and limitations.
@nl
P2860
P356
P1476
Use of SELDI-TOF mass spectrom ...... rs: potential and limitations.
@en
P2093
Robert Siegmund
P2860
P304
P356
10.1515/CCLM.2007.351
P577
2007-01-01T00:00:00Z